Гиляревский Сергей Руджерович


Сортировать:

THReshOld2024 ClinicalTrials.gov

Статус: Enrolling by invitation
Фаза: N/A
Начало: 1 апреля 2024 г.
Окончание: 1 июля 2025 г.
Описание: After checking the patient characteristics to the inclusion and exclusion criteria, and confirming the ability to complete the questionnaires provided by the study protocol, patients will be randomly assigned to 2 groups: a group with a higher target BP level (less than 135 mmHg) and a lower target BP level (less than 125 mmHg). Achievement of target BP levels will be assessed using a remote monitoring system. The study will identify factors that prevent achievement of target BP levels, as well as assess the efficacy, safety and tolerability of antihypertensive therapy (AHT).
смотреть на ClinicalTrials.gov